Literature DB >> 8751932

Gastric invasion by Trypanosoma cruzi and induction of protective mucosal immune responses.

D F Hoft1, P L Farrar, K Kratz-Owens, D Shaffer.   

Abstract

Trypanosoma cruzi is an intracellular parasite transmitted from a reduviid insect vector to humans by exposure of mucosal surfaces to infected insect excreta. We have used an oral challenge murine model that mimics vector-borne transmission to study T. cruzi mucosal infection. Although gastric secretions have microbicidal activity against most infectious pathogens, we demonstrate that T. cruzi can invade and replicate in the gastric mucosal epithelium. In addition, gastric mucosal invasion appears to be the unique portal of entry for systemic T. cruzi infection after oral challenge. The mucosal immune responses stimulated by T. cruzi gastric infection are protective against a secondary mucosal parasite challenge. This protective mucosal immunity is associated with increased numbers of lymphocytes that secrete parasite-specific immunoglobulin A. Our results document the first example of systemic microbial invasion through gastric mucosa and suggest the feasibility of a mucosal vaccine designed to prevent infection with this important human pathogen.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8751932      PMCID: PMC174296          DOI: 10.1128/iai.64.9.3800-3810.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  Suppression of cellular responses in mice during Trypanosoma cruzi infections.

Authors:  E C Rowland; R E Kuhn
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

Review 2.  Immunity to Trypanosoma cruzi.

Authors:  Z Brener
Journal:  Adv Parasitol       Date:  1980       Impact factor: 3.870

Review 3.  Biology of Trypanosoma cruzi.

Authors:  Z Brener
Journal:  Annu Rev Microbiol       Date:  1973       Impact factor: 15.500

4.  Trypanosoma cruzi--milk transmission of infection and immunity from mother to young.

Authors:  M A Miles
Journal:  Parasitology       Date:  1972-08       Impact factor: 3.234

5.  [Epidemiology of the first autochthonous cases of Chagas' disease recorded in Belém, Pará, Brazil].

Authors:  J Shaw; R Lainson; H Fraiha
Journal:  Rev Saude Publica       Date:  1969       Impact factor: 2.106

6.  Possible oral transmission of acute Chagas' disease in Brazil.

Authors:  M A Shikanai-Yasuda; C B Marcondes; L A Guedes; G S Siqueira; A A Barone; J C Dias; V Amato Neto; J E Tolezano; B A Peres; E R Arruda Júnior
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1991 Sep-Oct       Impact factor: 1.846

7.  Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection.

Authors:  R L Tarleton; B H Koller; A Latour; M Postan
Journal:  Nature       Date:  1992-03-26       Impact factor: 49.962

8.  Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice.

Authors:  F Torrico; H Heremans; M T Rivera; E Van Marck; A Billiau; Y Carlier
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

9.  [Trypanosoma cruzi in the milk of women with chronic Chagas disease].

Authors:  V Amato Neto; L Matsubara; R Campos; A A Moreira; P L Pinto; R Faccioli; M Zugaib
Journal:  Rev Hosp Clin Fac Med Sao Paulo       Date:  1992 Jan-Feb

10.  Experimental Chagas' disease: kinetics of lymphocyte responses and immunological control of the transition from acute to chronic Trypanosoma cruzi infection.

Authors:  M M Hayes; F Kierszenbaum
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

View more
  30 in total

1.  Type 1 immunity provides optimal protection against both mucosal and systemic Trypanosoma cruzi challenges.

Authors:  D F Hoft; C S Eickhoff
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

2.  Importance of the CCR5-CCL5 axis for mucosal Trypanosoma cruzi protection and B cell activation.

Authors:  Nicole L Sullivan; Christopher S Eickhoff; Xiuli Zhang; Olivia K Giddings; Thomas E Lane; Daniel F Hoft
Journal:  J Immunol       Date:  2011-06-29       Impact factor: 5.422

3.  Role of GP82 in the selective binding to gastric mucin during oral infection with Trypanosoma cruzi.

Authors:  Daniela I Staquicini; Rafael M Martins; Silene Macedo; Gisela R S Sasso; Vanessa D Atayde; Maria A Juliano; Nobuko Yoshida
Journal:  PLoS Negl Trop Dis       Date:  2010-03-02

4.  Type 1 immunity provides both optimal mucosal and systemic protection against a mucosally invasive, intracellular pathogen.

Authors:  Daniel F Hoft; Chris S Eickhoff
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

5.  Oral infection of mice and host cell invasion by Trypanosoma cruzi strains from Mexico.

Authors:  Cecilia G Barbosa; César Gómez-Hernández; Karine Rezende-Oliveira; Marcos Vinicius Da Silva; João Paulo Ferreira Rodrigues; Monique G S Tiburcio; Thatiane Bragini Ferreira; Virmondes Rodrigues; Nobuko Yoshida; Luis E Ramirez
Journal:  Parasitol Res       Date:  2019-03-08       Impact factor: 2.289

6.  Trypanosoma cruzi 13C-labeled O-Glycan standards for mass spectrometry.

Authors:  M Osman Sheikh; Elisabet Gas-Pascual; John N Glushka; Juan M Bustamante; Lance Wells; Christopher M West
Journal:  Glycobiology       Date:  2019-04-01       Impact factor: 4.313

7.  Clinical outcomes of thirteen patients with acute chagas disease acquired through oral transmission from two urban outbreaks in northeastern Brazil.

Authors:  Claudilson J C Bastos; Roque Aras; Gildo Mota; Francisco Reis; Juarez Pereira Dias; Robson Silva de Jesus; Miralba Silva Freire; Eline G de Araújo; Juliana Prazeres; Maria Fernanda Rios Grassi
Journal:  PLoS Negl Trop Dis       Date:  2010-06-15

8.  Differential interleukin-8 and nitric oxide production in epithelial cells induced by mucosally invasive and noninvasive Trypanosoma cruzi trypomastigotes.

Authors:  C S Eickhoff; L Eckmann; D F Hoft
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

9.  Infection by Trypanosoma cruzi metacyclic forms deficient in gp82 but expressing a related surface molecule, gp30.

Authors:  Mauro Cortez; Ivan Neira; Daniele Ferreira; Alejandro O Luquetti; Anis Rassi; Vanessa D Atayde; Nobuko Yoshida
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

10.  Involvement of Trypanosoma cruzi metacyclic trypomastigote surface molecule gp82 in adhesion to gastric mucin and invasion of epithelial cells.

Authors:  Ivan Neira; Fernando A Silva; Mauro Cortez; Nobuko Yoshida
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.